FUSE-AI

FUSE-AI GmbH is an E-Health company based in Hamburg, founded in 2017 by four experienced entrepreneurs. The company's goal is to improve medical care through the use of intelligent software solutions and artificial intelligence (AI).

FUSE-AI develops and implements AI-based solutions specifically designed for radiology. A central product is the algorithm prostate.Carcinoma.ai, which analyzes radiological images, particularly MRI scans, and detects and classifies carcinomas. This algorithm marks abnormalities and assesses whether they are benign or malignant tumors, significantly assisting radiologists in diagnosis and enhancing diagnostic quality[1][3][4].

Other projects include the development of a deep-learning-based assistance system for the diagnosis of prostate cancer without contrast agents in collaboration with the University Hospital Jena, as well as the KIRMES project, which aims to identify poorly healing bone fractures early and treat them with targeted therapies[2].

The main mission of FUSE-AI is to improve healthcare through the use of AI. The company aims to enhance diagnostic and therapeutic options to increase the quality of patient care. FUSE-AI is committed to providing a more precise, faster, and cost-effective medical diagnosis, ultimately improving the chances of recovery for patients[3][5].

FUSE-AI is engaged in several sustainable initiatives. By utilizing AI in medical diagnosis, costs for the healthcare system can be reduced, the workload for doctors minimized, and the chances of recovery for patients increased. The company is working on the development of cloud-based solutions that can be easily integrated into existing teleradiological infrastructures, ensuring a scalable and secure IT infrastructure[3][4].

Additionally, FUSE-AI is involved in various research projects supported by public funding, such as from the Federal Ministry of Education and Research (BMBF) and VDI / VDE Innovation and Technology GmbH. These projects aim to improve medical care in various areas, including the early detection of bone fractures and support for physiotherapeutic treatments[2].

FUSE-AI emphasizes the importance of strategic research collaborations with regional, national, and international partners from academia and industry. The company works closely with universities, clinics, and other research institutions to develop and validate innovative solutions. An example of this is the collaboration with the Fraunhofer Institute for Biomedical Engineering (IBMT) and Charité Berlin in developing the UltraWear app, which offers AI-supported biofeedback for physiotherapeutic exercises[2].

Through the use of big data analytics and AI, FUSE-AI makes a significant contribution to improving medical diagnosis and therapy, ultimately leading to better patient care and a more sustainable healthcare system.

• 1 - https://www.xlifesciences.ch/projects/fuse-ai
• 2 - https://company.fuse-ai.de
• 3 - https://www.t-systems.com/de/de/referenzen/cloud-und-infrastructure/fuse-ai-open-telekom-cloud
• 4 - https://www.telekom-healthcare.com/it-projekte-gesundheitswesen/fuse-ai-und-open-telekom-cloud
• 5 - https://fuse-ai.de